Heparin kinetics: variables related to disposition and dosage

Area of Science:

• Pharmacology
• Clinical Medicine
• Thrombosis Research

Background:

• Heparin is a critical anticoagulant for thromboembolic disease.
• Individual responses to heparin vary significantly, complicating dosage.
• Accurate heparin dosing is essential for therapeutic efficacy and safety.

Purpose of the Study:

• To develop a method for determining individual heparin kinetics.
• To identify factors influencing heparin dosage requirements.
• To establish a predictive model for heparin dosing.

Main Methods:

• Assessed heparin sensitivity and its relation to activated partial thromboplastin times (APTTs).
• Measured serial APTTs and estimated heparin concentrations post-bolus dose.
• Determined heparin elimination rate, distribution volume, and clearance.
• Developed a multiple regression model incorporating patient-specific factors.

Main Results:

• Observed a 500% range in pretreatment heparin sensitivities.
• Smokers exhibited faster heparin elimination and shorter half-lives (t 1/2s).
• Men demonstrated more rapid heparin clearance than women.
• Body weight, sex, symptom onset to treatment delay, and smoking status were significant predictors of dosage requirements.
• The developed model explained 78% of the variance in heparin requirements.

Conclusions:

• Individualized heparin dosing is crucial due to wide variations in sensitivity and kinetics.
• Patient characteristics including smoking status, sex, body weight, and treatment delay significantly impact heparin dosage.
• A predictive model integrating these factors can optimize heparin therapy for thromboembolic disease.